Comparison of Glargine to Degludec Insulin Transition With or Without a Bridging Glargine Dose

NCT04623086 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

59

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: Insulin Degludec
DRUG: Insulin Glargine
DRUG: Placebo

Sponsor

University of Washington